Efficacy of tyrosine kinase inhibitors in EGFR -mutant lung cancer women in a real-world setting: the WORLD07 database

ConclusionPrevalence ofEGFR mutation in women with NSCLC is higher than overall population with NSCLC. Efficacy of EGFR TKI in this real-world setting is similar to that previously reported. (Source: Clinical and Translational Oncology)

from MedWorm via o.lakala70 on Inoreader http://ift.tt/2sRU4yF
via IFTTT